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Abstract
In the absence of oxygen many bacteria are able to utilise fumarate as a terminal oxidant for respiration. In most known
organisms the fumarate reductases are membrane-bound iron-sulfur flavoproteins but Shewanella species produce a soluble,
periplasmic flavocytochrome c3 that catalyses this reaction. The active sites of all fumarate reductases are clearly conserved at
the structural level, indicating a common mechanism. The structures of fumarate reductases from two Shewanella species
have been determined. Fumarate, succinate and a partially hydrated fumarate ligand are found in equivalent locations in
different crystals, tightly bound in the active site and close to N5 of the FAD cofactor, allowing identification of amino acid
residues that are involved in substrate binding and catalysis. Conversion of fumarate to succinate requires hydride transfer
from FAD and protonation by an active site acid. The identity of the proton donor has been open to question but we have
used structural considerations to suggest that this function is provided by an arginine side chain. We have confirmed this
experimentally by analysing the effects of site-directed mutations on enzyme activity. Substitutions of Arg402 lead to a
dramatic loss of activity whereas neither of the two active site histidine residues is required for catalysis. ß 2000 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Shewanella species are widespread Gram-negative
proteobacteria and are particularly abundant in ma-
rine and freshwater sediments. They are remarkable
in their diversity of respiratory pathways [1,2] and
can utilise many inorganic and organic electron ac-
ceptors, including fumarate, nitrate, trimethylamine
N-oxide, thiosulphate and, more unusually, insoluble
oxides of Fe(III) and Mn(IV). The diversity of
known respiratory pathways is matched by a large
number of redox proteins. Several have been identi-
¢ed biochemically but it is clear from examination of
the genome sequence of Shewanella MR-1 (available
at www.tigr.org) that a very large number of unchar-
acterised cytochromes and other electron transfer
proteins are produced. When Shewanella frigidimar-
ina NCIMB400 (formerly Shewanella putrefaciens) is
grown anaerobically, it produces large quantities of
several c-type cytochromes [3]. The most abundant
of these is a 64 kDa £avocytochrome that catalyses
methyl viologen-dependent fumarate reduction in vi-
tro [4,5]. The role of this £avocytochrome c3 (Fcc3)
in fumarate respiration has been shown using a null
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mutant constructed by gene disruption [6]. The mu-
tant is incapable of fumarate respiration but path-
ways to other electron acceptors are una¡ected.
This speci¢c defect shows not only that £avocyto-
chrome c3 is required for fumarate respiration but
its function cannot be performed by other proteins
produced under these conditions. This implies that
no membrane-bound fumarate reductase is pro-
duced. It appears, surprisingly, that the genome of
Shewanella MR-1 includes an operon that is very
similar to the Wolinella Frd operon that encodes
the membrane-bound fumarate reductase, even
though this strain also produces a soluble £avocyto-
chrome c3 fumarate reductase [7]. Whether a similar
Frd operon is present in NCIMB400 is not yet
known. If so then its role in fumarate respiration is
unclear since the Fcc3 knockout strain failed to grow
with fumarate as terminal electron acceptor. It has
been shown that S. frigidimarina NCIMB400 produ-
ces a second £avocytochrome c3 (Ifc3) which also
e⁄ciently reduces fumarate in vitro [8]. However,
this protein is speci¢cally induced by Fe(III) and its
physiological function is poorly understood.
Shewanella species are the only bacteria known to
produce soluble respiratory fumarate reductases. In
other organisms fumarate is reduced by a membrane-
bound complex of either three or four subunits [9].
These enzymes are closely related in structure and
activity to succinate dehydrogenases which catalyse
the reverse reaction. All fumarate reductases and suc-
cinate dehydrogenases contain FAD at the active site
but electron transfer to the £avin is mediated by
three iron-sulfur centres in the membrane-bound en-
zymes whereas the four haem centres of £avocyto-
chrome c3 perform the equivalent function. The
FAD-binding catalytic domain or subunit is highly
conserved within and between these groups of en-
zymes indicating that the catalytic mechanism is
likely to be very similar in all cases.
2. Fumarate reductase structure
The determination of the high-resolution crystal
structure of Shewanella fumarate reductase ([10,11];
PDB references 1QJD, 1D4C) has provided major
insights into substrate binding and catalysis. The
protein consists of a single polypeptide organised
into three distinct domains (Fig. 1). The small, N-
terminal, cytochrome domain containing four haem
groups is tethered to the £avin domain by a charged
bent helix linker (residues 100^110). The £avin do-
Fig. 1. Domain structure of S. frigidimarina fumarate reductase. The polypeptide chain is shown as a ribbon diagram with the cyto-
chrome, £avin-binding and clamp domains coloured green, cyan and magenta, respectively. The haem groups are shown in red (with
the iron in grey) and the £avin is in yellow.
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main (residues 111^364 and 503^571, coloured cyan
in Fig. 1) holds the non-covalently bound FAD
group. The overall fold of the FAD binding domain
has a structural and topological similarity with
known FAD binding proteins, though sequence sim-
ilarity is poor [12]. Buried within the £avin domain is
an octahedrally coordinated sodium ion which is
close to the active site and may well play a structural
or regulatory role. The clamp domain of Fcc3 (resi-
dues 365^502) is likely to be involved in controlling
access of substrate to the active site. It consists of
seven short helical stretches wrapped round a four-
stranded antiparallel sheet.
The crystallisation medium contained a 10 mM
solution of fumarate, well above the Km of 25 WM,
suggesting that the active site of Fcc3 should be fully
occupied. However, the electron density map clearly
shows the presence of a hydrated, malate-like mole-
cule in the active site of Fcc3 (Fig. 2). It is unlikely
that this molecule is oxaloacetate because the protein
is crystallised from fully active enzyme in the com-
plete absence of this compound. The malate-like
molecule is held tightly by several hydrogen bonds
and sits in a close-¢tting binding site that is com-
pletely inaccessible to solvent [10].
The absence of a solvent-accessible channel to the
active site implies that there must be signi¢cant do-
main movement to enable substrate binding and
product release. The active site is at the interface
between the £avin-binding and clamp domains,
both of which contribute important active site resi-
dues. We presume that the closed conformation that
we observe when crystals are grown in the presence
of fumarate represents a close approximation to the
catalytically competent state. The enzyme is found in
this form with either substrate or product bound in
the active site [10] and it also appears that, in the
absence of available reducing equivalents, the en-
zyme is still capable of modifying the substrate by
nucleophilic attack [11]. The relative positions of
the two domains are somewhat variable in the di¡er-
ent fumarate reductase structures and more espe-
cially in L-aspartate oxidase [13], a closely related
enzyme that can also reduce fumarate. This protein
was crystallised in an open conformation with no
substrate bound ^ indeed the FAD cofactor had
also dissociated. We conclude that domain move-
ment is an important feature of these enzymes with
opening being necessary for access to the active site
and closure being essential for catalysis as described
below.
3. Electron transfer
The pathway from membrane-bound quinols to
the fumarate reductase in Shewanella is not well
understood, but a membrane-bound tetrahaem cyto-
chrome c has been implicated in electron transfer to
fumarate reductase and other terminal reductases.
This protein, CymA [14], is related to the NirT/
NapC family. It is not known whether this protein
directly reduces £avocytochrome c3 but the organi-
sation of the Fcc3 cytochrome domain, with at least
three of its four haems highly accessible to solvent,
indicates that electron transfer should be facile. The
edge-to-edge distances between pairs of haems in
Fcc3 range from a mere 3.9 Aî to 8.0 Aî and the
shortest haem-FAD distance is just 7.4 Aî . All of
these distances are commensurate with very rapid
internal electron transfer. The thermodynamic prop-
erties of the redox centres have been determined by
potentiometric measurements and by protein ¢lm
voltammetry [15]. The reduction potentials of the
haems are low, ranging from 3238 to 3102 mV at
pH 7.0 and 25‡C with the FAD potential at 3154
mV, giving a substantial driving force for fumarate
reduction.
Fig. 2. The environment of the modi¢ed substrate in the active
site. The malate-like molecule is shown with hydrogen bonds to
Arg544, His504 and His 365 as dotted lines. The distances rele-
vant for hydride and proton transfer are indicated.
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4. Substrate binding and catalysis
The malate-like molecule found in the active site is
tightly bound and inaccessible to solvent. Its binding
is indistinguishable from fumarate bound in the ac-
tive site of fumarate reductase from Shewanella
MR-1 [11]. The C4 carboxylate is bound in a highly
polar environment by electrostatic interaction and
hydrogen bonds to Arg544 and Arg402 and by a
hydrogen bond to His504 (Fig. 2). The environment
of the C1 carboxylate is much less polar but hydro-
gen bond interactions with Thr377 and His365 are
observed.
Two signi¢cant features of substrate binding ap-
pear critical for the reaction mechanism (Fig. 3).
Normally fumarate is a symmetrical, planar, sub-
strate. Reduction to succinate involves the transfer
of a hydride from N5 of the FAD to C2 and a pro-
ton to C3 resulting in a non-planar product. This
reaction is facilitated by an induced polarisation of
the substrate, resulting from the charge asymmetry in
the binding pocket and by an induced loss of planar-
ity upon binding to the enzyme. This results from the
close interaction of the C1 carboxylate with the side
chains of Met236 and Met375, too close to allow
substrate to bind as a planar molecule. Met236 is
in the £avin-binding domain whereas Met375 is a
clamp domain residue so it seems that the substrate
distortion is a feature of domain closure around the
active site. The orientation of the C1 carboxylate by
hydrogen bonds to His365 and Thr377 may facilitate
domain closure and provide the drive to twist the
substrate out of the planar conformation with the
additional e¡ect of weakening the conjugated double
bonds. The exceptionally polar hydrogen bonding
environment of the C4 carboxyl group with contri-
butions from two arginines and a histidine, acts to
polarise the fumarate. The combined steric and elec-
tronic e¡ects then reinforce each other to generate
considerable positive charge at C2 making it amena-
ble to nucleophilic attack.
The £avin N5 is positioned less than 3.2 Aî from
fumarate C2, poised to attack the si-face of the C2
centre. Hydride transfer to C2 is followed by proto-
nation of C3, resulting in formation of succinate; the
only residue su⁄ciently close to C3 for protonation
is Arg402 at a distance of 2.99 Aî . The role of this
residue is discussed in detail below. Under the oxi-
Fig. 3. The mechanism of fumarate reduction. The key residues
are shown schematically with hydrogen bonds as dashed lines.
The proposed mechanism is described in the text.
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dising conditions that were used for crystal growth,
hydride attack is not possible and instead there is
attack by H2O on the re-face to provide the observed
product which has R-stereochemistry at C2 [10].
5. Proton transfer
The structures of ¢ve fumarate reductases from
Shewanella [10,11,16], Escherichia coli [17] and Woli-
nella succinogenes [18] indicate a common mechanism
for substrate binding and activation, suitably posi-
tioned for hydride transfer. Completion of product
formation also requires protonation at C3 and the
source of the proton has been the subject of some
debate.
Prior to the crystallographic results, it was gener-
ally expected that a histidine would act as the acid/
base catalyst in fumarate reductases and succinate
dehydrogenases. This expectation was based on the
widespread use of histidines in proton transfer in
many types of enzyme and the fact that chemical
modi¢cation studies with succinate dehydrogenase
indicated that a histidine residue played an important
catalytic role [19]. Analysis of the structure shows
that the two active site histidines, His365 and
His504, are each hydrogen-bonded to substrate car-
boxylate oxygens and not well positioned for proton
transfer, being too distant from the substrate C3. To
probe the roles of these residues and their possible
involvement in substrate protonation as suggested
elsewhere (e.g. [16]) we have used site-directed muta-
genesis to convert each to alanine [20]. The H365A
and H504A mutant enzymes exhibited lower kcat val-
ues than the wild-type enzyme (Table 1) but only by
factors of 3^15, depending on pH. This, coupled with
the increase in Km observed for these enzymes, indi-
cates that His365 and His504 are primarily involved
in Michaelis complex formation and are not essential
catalytic residues.
The structures of two of the Shewanella enzymes
[10,11] and E. coli fumarate reductase [17] clearly
show NH2 of Arg402 close to the substrate C3, the
eventual proton acceptor. When we altered Arg402
to Ala we could not detect fumarate reductase assay
in the recombinant enzyme, indicating a key role for
this arginine. Interestingly we have recently substi-
tuted Arg402 with a lysine residue and the enzyme
now exhibits activity, albeit at an extremely low level
(Table 1).
Since the active site is inaccessible to solvent, de-
livery of a proton to Arg402 may appear problem-
atic. However, a putative pathway for proton trans-
fer is readily observed in that Glu378 forms a bridge
between Arg402 and a conserved surface residue,
Arg381 (Fig. 4). These residues are completely con-
served, consistent with such an important function.
In the structure of the Wolinella fumarate reduc-
tase [18], the position of the residue equivalent to
Arg402 in the Shewanella enzyme (Arg301) has
moved by about 3 Aî compared to the Shewanella
Fig. 4. The putative proton delivery pathway. Arg381 is ex-
posed to solvent and close interactions indicate a pathway for
rapid proton transfer to the substrate via Glu378 and Arg402.
Table 1
Comparison of kcat and Km values for wild-type, H365A,
H504A and R402K Fcc3 (pH 7.2, 25‡C, I = 0.45 M)
Form of Fcc3 kcat (s31) Km (WM)
Wild-type 509 þ 15 25 þ 10
H365A 51 þ 2 259 þ 24
H504A 65 þ 3 256 þ 23
R402K 0.055 þ 0.004 66 þ 14
No activity was detected with the R402A enzyme.
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and E. coli enzyme structures. An overlay of the
£avin binding domains of all structures shows that
the conserved catalytic residues of the £avin-binding
domain are very similar. The residues on the clamp
domain di¡er in position by between 1 and 3 Aî ,
corresponding to an opening of the clamp in the
Wolinella enzyme structure [18]. It should be noted
that this structure was determined with crystals that
had had substrate di¡used in ^ they may have been
trapped in a slightly open conformation. The fact
that the position of the arginine side chain is some-
what altered in the Wolinella fumarate reductase has
led Lancaster and colleagues to propose that the pro-
ton comes instead from a water molecule [18]. How-
ever, if the clamp domain in the Wolinella enzyme is
moved to the orientation (i.e. the closed form) seen
in the other fumarate reductases then the position of
the arginine side chain is comparable to that seen in
all the other structures. Thus we are convinced that
our mechanism (Fig. 3), involving hydride transfer
from £avin N5 and proton transfer from this con-
served arginine residue, applies for all members of
the fumarate reductase family.
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